Page 153 - Genentech News Today

(Reuters) -Swiss drugmaker Roche Holding AG plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will shut the factory by 2029, according to e-mailed letters to workers seen by Reuters on Wednesday. | 06:20pm

Menlo Park, California (PRWEB) May 30, 2023 -- Equify Health, an innovation firm working to transform patient-provider experiences, was awarded a $1 million

(Reuters) -Swiss drugmaker Roche Holding AG plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will shut the factory by 2029, according to e-mailed letters to workers seen by Reuters on Wednesday. | 06:20pm

Healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

/PRNewswire/ -- DelveInsights CTLA-4 Inhibitors Competitive Landscape – 2023 report provides comprehensive global coverage of available, marketed, and...

(Reuters) -Swiss drugmaker Roche Holding AG plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will shut the factory by 2029, according to e-mailed letters to workers seen by Reuters on Wednesday. | 06:20pm

EyePoint Pharmaceuticals is a $200m market cap biotech focused on eye disease. Read more to see a full investment analysis of EYPT stock.

OSLO, Norway, May 30, 2023 -- Nykode Therapeutics ASA , a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that its... | May 30, 2023

Insurancenewsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insurancenewsnet.com Daily Mail and Mail on Sunday newspapers.

The Willchair is all about “reimagining the future, beyond multiple sclerosis,” according to the campaign’s website.